Search Results 8321-8330 of 34195 for oral

1. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Able to swallow and retain oral medications and without gastrointestinal (GI) illnesses that would preclude absorption of cediranib or olaparib; Women of ...

2. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

   Cladribine, mitoxantrone, or oral cyclophosphamide at any time. Treatment with any investigational agent within 24 weeks or 5 drug-elimination half-lives of ...

3. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

   Requires intermittent or chronic systemic (intravenous or oral) treatment with an antiherpetic drug (eg, acyclovir), other than intermittent topical use ...

4. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   Able to swallow oral medication. Both female and male patients of reproductive potential must agree to avoid pregnancy or impregnating a partner ...

5. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

   Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

6. Pamidronate (intravenous route) - Side effects & dosage - Mayo Clinic

   May make these conditions worse. Cancer, history of or; Dental or tooth problems or; Dental procedures or; Poor oral hygiene or; Surgery (e.g., dental surgery) ...

7. Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) - Mayo Clinic

   ... (oral, implant, ring, patch, IUD) for the duration of the program until at least 30 days after the last DefenCath CLS instillation. (NOTE: The participant ...

8. Neurology - Doctors - Mayo Clinic

   oral lobe seizure, Seizure , Absence seizure, Febrile seizure. Show more areas of focus for Anthony L. Fine, M.D.. Sanford M. Fineman ...

9. A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550 (FIBRONEER™-ON) - Mayo Clinic

   WOCBP taking oral contraceptives (OCs) also have to ensure the use of one barrier method during sexual intercourse with their partner, e.g., condom to ...

10. Transoral robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Laryngeal cancer, Skin tumor. Show more areas of focus for Katie M. Van Abel, M.D.. Research. Doctors and scientists involved in ...